Effects of BRAF and ERK inhibition on papillary and anaplastic thyroid cancer

ABSTRACT: To investigate the effects of combined BRAF inhibition (dabrafenib) and ERK inhibition (ulixertinib) on papillary and anaplastic thyroid cancer transcriptional reprogramming

ORGANISM(S): Homo sapiens

PROVIDER: GSE221329 | GEO | 2023/06/15

REPOSITORIES: GEO